Frexalimab, a therapy Sanofi is developing for multiple sclerosis (MS) patients, led to sustained reductions in disease activity in people with relapsing forms of MS over more than two years […] The post ECTRIMS 2025: Frexalimab shows long-term benefits for MS patients appeared first on Multiple Sclerosis News Today. Source: multiplesclerosisnewstoday.com
Month: October 2025
ECTRIMS 2025: Ultra-processed foods may fuel disease in early MS
Consuming large amounts of ultra-processed foods (UPF) — products high in additives, artificial ingredients, and extensive processing — is associated with increased disease activity in people with clinically isolated syndrome […] The post ECTRIMS 2025: Ultra-processed foods may fuel disease in early MS appeared first on Multiple Sclerosis News Today. Source: multiplesclerosisnewstoday.com
Amanda Chavez – MSAA’s October 2025 Artist of the Month
MSAA features the work of many talented artists affected by multiple sclerosis as part of our annual MSAA Art Showcase. Each month we share these artists’ inspiring stories and beautiful artwork with you as our Artist of the Month. This month, we celebrate Amanda … Continue reading → Source: blog.mymsaa.org
Q&A October
Tweet Have any questions? Source: multiple-sclerosis-research.org